Results
Differentially Expressed miRNAs List
| miRNA ID | Source ID | Cancer Type | Cancer Subtype | Cell Line | Design | logFC | Expression Status | Experiment ID |
|---|---|---|---|---|---|---|---|---|
| hsa-miR-222 | GSE5244 | uterus cancer | uterus cancer | N/A | cancer vs normal | 0.17 | UP | EXP00030 |
| hsa-miR-222 | GSE6188 | esophageal cancer | esophageal cancer | N/A | cancer vs normal | -0.20 | DOWN | EXP00031 |
| hsa-miR-222 | GSE6636 | prostate cancer | prostate cancer | N/A | cancer vs normal | -3.24 | DOWN | EXP00032 |
| hsa-miR-222 | GSE10694 | hepatocellular carcinoma | hepatocellular carcinoma | N/A | cancer vs normal | 1.52 | UP | EXP00051 |
| hsa-miR-222 | GSE10694 | hepatocellular carcinoma | hepatocellular carcinoma | N/A | cancer vs normal | 1.31 | UP | EXP00052 |
| hsa-miR-222 | GSE7828 | colon cancer | colon cancer | N/A | cancer vs normal | 0.35 | UP | EXP00084 |
| hsa-miR-222 | GSE22058 | hepatocellular carcinoma | hepatocellular carcinoma | N/A | cancer vs normal | 0.28 | UP | EXP00100 |
| hsa-miR-222 | GSE21036 | prostate cancer | prostate cancer | N/A | cancer vs normal | -1.47 | DOWN | EXP00101 |
| hsa-miR-222 | GSE21036 | prostate cancer | prostate cancer | N/A | metastasis | -1.65 | DOWN | EXP00102 |
| hsa-miR-222 | GSE16456 | esophageal cancer | esophageal cancer | N/A | cancer vs normal | -1.15 | DOWN | EXP00075 |
| hsa-miR-222 | GSE6857 | hepatocellular carcinoma | hepatocellular carcinoma | N/A | cancer vs normal | 0.71 | UP | EXP00081 |
| hsa-miR-222 | GSE13030 | brain cancer | brain cancer | N/A | cancer vs normal | -1.13 | DOWN | EXP00066 |
| hsa-miR-222 | GSE2399 | leukemia | leukemia | Jurkat | subtype1 vs substype2 | 0.85 | UP | EXP00017 |
| hsa-miR-222 | GSE2564 | leukemia | leukemia | N/A | subtype1 vs substype2 | 1.66 | UP | EXP00026 |
| hsa-miR-222 | GSE4589 | breast cancer | breast cancer | N/A | cancer vs normal | -1.67 | DOWN | EXP00029 |